Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structu...

Full description

Saved in:
Bibliographic Details
Main Authors: Zainab Afshan Sheikh, Helen Yu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Responsible Innovation
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556112256532480
author Zainab Afshan Sheikh
Helen Yu
author_facet Zainab Afshan Sheikh
Helen Yu
author_sort Zainab Afshan Sheikh
collection DOAJ
description Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.
format Article
id doaj-art-a59a4ead697546999a7dfeabfa28189d
institution Kabale University
issn 2329-9460
2329-9037
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Responsible Innovation
spelling doaj-art-a59a4ead697546999a7dfeabfa28189d2025-01-07T13:48:20ZengTaylor & Francis GroupJournal of Responsible Innovation2329-94602329-90372024-12-0111110.1080/23299460.2024.2316363Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery researchZainab Afshan Sheikh0Helen Yu1Faculty of Law, Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, DenmarkDepartment of Public Health, Center for Medical Science and Technology Studies, University of Copenhagen, Copenhagen, DenmarkEnsuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363Responsible Research and Innovationstakeholder engagementdrug discoveryscience-society relationssemi-structured interviews
spellingShingle Zainab Afshan Sheikh
Helen Yu
Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
Journal of Responsible Innovation
Responsible Research and Innovation
stakeholder engagement
drug discovery
science-society relations
semi-structured interviews
title Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_full Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_fullStr Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_full_unstemmed Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_short Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_sort perspectives of copd patients publicly funded scientists and industry representatives on responsibility and stakeholder engagement in drug discovery research
topic Responsible Research and Innovation
stakeholder engagement
drug discovery
science-society relations
semi-structured interviews
url https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363
work_keys_str_mv AT zainabafshansheikh perspectivesofcopdpatientspubliclyfundedscientistsandindustryrepresentativesonresponsibilityandstakeholderengagementindrugdiscoveryresearch
AT helenyu perspectivesofcopdpatientspubliclyfundedscientistsandindustryrepresentativesonresponsibilityandstakeholderengagementindrugdiscoveryresearch